Clinical Updates

Tranzyme Pharma said its experimental drug to improve gastrointestinal recovery after surgery failed to meet the main or secondary goals… »   

Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan… »   

The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration,… »   

A new medical survey has come up with disturbing a revelation; more than a third of malaria medicines on the… »   

MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Trading Symbol: MNOV) and the Jasdaq Market of the… »   

It was clear that San Diego’s MediciNova had a lot riding on the outcome of a mid-stage trial of the… »   

Adding more weight to concerns about possible long-term dangers of osteoporosis drugs, a new study finds that people who… »   

Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest… »   

Adding Johnson & Johnson’s advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first… »   

A U.S. Food and Drug Administration advisory panel recommended Tuesday approval of the first HIV test that would give people… »   

The Food and Drug Administration is questioning the benefits and risks of a new rheumatoid arthritis drug created by Pfizer,… »   

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that typically affects the hands and feet, although any joint lined… »   

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug… »   

Officials of India’s drug regulator have been colluding with pharmaceutical firms to speed up approval procedures, allowing some drugs that… »   

GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its… »